3-Methylfentanyl

From Wikipedia, the free encyclopedia
Jump to: navigation, search
3-Methylfentanyl
3-Methylfentanyl.svg
Systematic (IUPAC) name
(RS)-N-(3-methyl-1-phenethyl-4-piperidyl)-N-phenyl-propanamide
Clinical data
Legal status
Identifiers
CAS number 42045-86-3 N
ATC code ?
PubChem CID 61996
DrugBank DB01571
ChemSpider 55844 YesY
ChEBI CHEBI:61092 YesY
Synonyms 3-methylfentanyl, Mefentanyl
Chemical data
Formula C23H30N2O 
Mol. mass 350.497 g/mol
 N (what is this?)  (verify)

3-Methylfentanyl (3-MF, mefentanyl) is an opioid analgesic that is an analog of fentanyl. 3-Methylfentanyl is one of the most potent drugs that has been widely sold on the black market, estimated to be between 400 and 6000 times stronger than morphine,[1] depending on which isomer is used (with the cis isomers being the more potent ones).[2][3]

3-Methylfentanyl was first discovered in 1974[4] and subsequently appeared on the street as an alternative to the clandestinely produced fentanyl analog α-methylfentanyl. However, it quickly became apparent that 3-methylfentanyl was much more potent than α-methylfentanyl, and correspondingly even more dangerous.[5]

While 3-methylfentanyl was initially sold on the black market for only a short time between 1984 and 1985, its high potency made it an attractive target to clandestine drug producers, as racemic 3-MF is 10–15 times more potent than fentanyl, and so correspondingly larger amounts of cut product for street sales can be produced for an equivalent amount of effort as for producing fentanyl itself; one gram of 3-methylfentanyl might be sufficient to produce several thousand dosage units once diluted for sale. 3-MF has thus reappeared several times, at various places around the world.[6]

The only country in the world with significant (200+ deaths a year, more than 10 000 addicts) abuse of this chemical is Estonia, where a dose of 3-MF costs 10 €, and other opiates are not generally available.[7]

Other opioid analogs even more potent still than 3-MF are known, such as carfentanil and ohmefentanyl,[8] but these are significantly more difficult to manufacture than 3-methylfentanyl and have not been so well accepted as street drugs.

3-Methylfentanyl has similar effects to fentanyl, but is far more potent due to increased binding affinity to its target site. Since fentanyl itself is already highly potent, 3-methylfentanyl is extremely dangerous when used recreationally, and has resulted in many deaths among recreational opioid users ingesting the drug. Side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening.

Use as chemical weapon[edit]

3-Methylfentanyl was also reported by media as the identity of the anaesthetic "gas" Kolokol-1 delivered as an aerosol.[9] and used in the Moscow theater hostage crisis in 2002, in which many hostages died from accidental overdoses of the narcotic. The opiate antidote naloxone was on-hand to treat the victims of the crisis, but either due to their incarceration, lack of food water or sleep, or due to the novel nature of the still unconfirmed compound used, acute symptoms continued to develop and there were many fatalities regardless of the administration of naloxone.

Synthesis[edit]

A number of methods have been published. Most recent, is probably the method posted by the Serbian chemical society (2004).[10]

There is another method though, for constructing the N-Benzyl-3-methyl-4-piperidone in a 2-stage Michael reaction, followed by Dieckmann cyclization as per usual.

See also[edit]

References[edit]

  1. ^ Henderson GL. Designer Drugs: Past History and Future Prospects Journal of Forensic Science. 33(2): 569-575 (1988)
  2. ^ Jin, W. Q.; Xu, H.; Zhu, Y. C.; Fang, S. N.; Xia, X. L.; Huang, Z. M.; Ge, B. L.; Chi, Z. Q. (1981). "Studies on synthesis and relationship between analgesic activity and receptor affinity for 3-methyl fentanyl derivatives". Scientia Sinica 24 (5): 710–720. PMID 6264594.  edit
  3. ^ Wang, Z. X.; Zhu, Y. C.; Chen, X. J.; Ji, R. Y. (1993). "Stereoisomers of 3-methylfentanyl: synthesis, absolute configuration and analgesic activity". Yao xue xue bao = Acta pharmaceutica Sinica 28 (12): 905–910. PMID 8030414.  edit
  4. ^ Van Bever, W. F. M.; Niemegeers, C. J. E.; Janssen, P. A. J. (1974). "Synthetic analgesics. Synthesis and pharmacology of the diastereoisomers of N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide and N-[3-methyl-1-(1-methyl-2-phenylethyl)-4-piperidyl]-N-phenylpropanamide". Journal of Medicinal Chemistry 17 (10): 1047–1051. doi:10.1021/jm00256a003. PMID 4420811.  edit
  5. ^ Ayres, W. A.; Starsiak, M. J.; Sokolay, P. (1981). "The bogus drug: Three methyl & alpha methyl fentanyl sold as "China White"". Journal of Psychoactive Drugs 13 (1): 91–93. doi:10.1080/02791072.1981.10471455. PMID 7277090.  edit
  6. ^ Hibbs, J.; Perper, J.; Winek, C. L. (1991). "An outbreak of designer drug--related deaths in Pennsylvania". JAMA: the Journal of the American Medical Association 265 (8): 1011–1013. doi:10.1001/jama.265.8.1011. PMID 1867667.  edit
  7. ^ Ojanperä, I.; Gergov, M.; Liiv, M.; Riikoja, A.; Vuori, E. (2008). "An epidemic of fatal 3-methylfentanyl poisoning in Estonia". International journal of legal medicine 122 (5): 395–400. doi:10.1007/s00414-008-0230-x. PMID 18386033.  edit
  8. ^ Huang, Z. M.; Zhou, J.; Chen, X. J.; Zheng, W. J.; Zhang, H. P.; Chi, Z. Q.; Li, Z. G.; Chen, W. L. (1984). "Analgesic activity and toxicity of potent analgesics, ohmefentanyl and mefentanyl". Zhongguo yao li xue bao = Acta pharmacologica Sinica 5 (3): 153–158. PMID 6239505.  edit
  9. ^ "Moscow Theater Crisis: Unknown Chemical Agent Revisited". Bruker Detection. March 10, 2014. 
  10. ^ http://www.doiserbia.nb.rs/img/doi/0352-5139/2004/0352-51390407511I.pdf
  11. ^ Mićović, I. V.; Ivanović, M. D.; Vuckovic, S. M.; Prostran, M. Š.; Došen-Mićović, L.; Kiricojević, V. D. (2000). "The Synthesis and preliminary pharmacological evaluation of 4-Methyl fentanyl". Bioorganic & Medicinal Chemistry Letters 10 (17): 2011. doi:10.1016/S0960-894X(00)00394-2.  edit